AxoGen, Inc.AXGNNASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 83% recommend buying.

Consensus Rating
Buy
18 analysts·Moderate coverage
83%
Rating Distribution
Strong Buy
00%
Buy
1583%
Hold
317%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 7% higher.

Bear Case
$34.00
-3%
Consensus
$37.43
+7%
Bull Case
$40.00
+14%
Price Range18 analysts
Low
Consensus
High
$34.00
$40.00
Current Target
Current Price
$35.02
Upside to Target
$2.41

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 5, 2025H.C. Wainwright
AxoGen price target raised to $39 from $26 at H.C. Wainwright
Target:$39.00
+15.7%from $33.70
Dec 5, 2025Canaccord Genuity
AxoGen price target raised to $37 from $27 at Canaccord
Target:$37.00
+12.6%from $32.85
Dec 4, 2025Raymond James
AxoGen, Inc. (AXGN) PT Raised to $36 at Raymond James
Target:$36.00
+8.5%from $33.19
Dec 4, 2025Lake Street
AxoGen price target raised to $40 from $30 at Lake Street
Target:$40.00
+24.6%from $32.10
Dec 4, 2025Jefferies
AxoGen price target raised to $36 from $29 at Jefferies
Target:$36.00
+27.1%from $28.33
Dec 1, 2025Mizuho Securities
AxoGen initiated with an Outperform at Mizuho
Target:$40.00
+39.6%from $28.65
Oct 30, 2025H.C. Wainwright
AxoGen price target raised to $26 from $25 at H.C. Wainwright
Target:$26.00
+13.7%from $22.86
Oct 30, 2025Canaccord Genuity
AxoGen price target raised to $27 from $24 at Canaccord
Target:$27.00
+21.3%from $22.25
Oct 30, 2025JMP Securities
AxoGen price target raised to $34 from $26 at Citizens JMP
Target:$34.00
+52.8%from $22.25
Sep 30, 2025H.C. Wainwright
AxoGen initiated with a Buy at H.C. Wainwright
Target:$25.00
+44.8%from $17.26